Bristol Gate Capital Partners Inc. reduced its stake in shares of McKesson Co. (NYSE:MCK – Free Report) by 4.2% during the 2nd quarter, HoldingsChannel reports. The fund owned 173,952 shares of the company’s stock after selling 7,681 shares during the period. McKesson accounts for about 5.0% of Bristol Gate Capital Partners Inc.’s holdings, making the stock its 2nd largest position. Bristol Gate Capital Partners Inc.’s holdings in McKesson were worth $101,595,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Swedbank AB purchased a new stake in McKesson during the 1st quarter valued at $669,326,000. TD Asset Management Inc increased its position in McKesson by 202.8% during the fourth quarter. TD Asset Management Inc now owns 602,138 shares of the company’s stock valued at $278,778,000 after acquiring an additional 403,312 shares during the last quarter. Bessemer Group Inc. raised its stake in shares of McKesson by 3,621.7% in the first quarter. Bessemer Group Inc. now owns 349,395 shares of the company’s stock valued at $187,572,000 after acquiring an additional 340,007 shares during the period. Third Point LLC bought a new stake in shares of McKesson in the 4th quarter worth about $76,392,000. Finally, American Century Companies Inc. boosted its stake in shares of McKesson by 134.6% during the 2nd quarter. American Century Companies Inc. now owns 220,619 shares of the company’s stock worth $128,850,000 after purchasing an additional 126,567 shares during the period. 85.07% of the stock is currently owned by hedge funds and other institutional investors.
McKesson Stock Performance
NYSE:MCK opened at $507.95 on Friday. The firm has a 50-day simple moving average of $561.63 and a 200-day simple moving average of $557.00. McKesson Co. has a one year low of $431.35 and a one year high of $637.51. The firm has a market cap of $66.00 billion, a P/E ratio of 22.70, a P/E/G ratio of 1.18 and a beta of 0.44.
McKesson Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 1st. Stockholders of record on Monday, September 2nd will be given a $0.71 dividend. The ex-dividend date is Friday, August 30th. This represents a $2.84 dividend on an annualized basis and a dividend yield of 0.56%. This is an increase from McKesson’s previous quarterly dividend of $0.62. McKesson’s payout ratio is presently 12.69%.
Analyst Ratings Changes
A number of analysts recently weighed in on the stock. Leerink Partners reduced their price objective on shares of McKesson from $670.00 to $665.00 and set an “outperform” rating on the stock in a research report on Thursday, September 5th. JPMorgan Chase & Co. raised their price target on McKesson from $656.00 to $661.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 21st. Argus upped their price objective on McKesson from $570.00 to $670.00 and gave the company a “buy” rating in a research report on Monday, June 24th. StockNews.com lowered McKesson from a “strong-buy” rating to a “buy” rating in a research note on Friday, August 9th. Finally, Evercore ISI lowered their target price on shares of McKesson from $660.00 to $630.00 and set an “outperform” rating for the company in a research note on Thursday, August 8th. Two equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $620.93.
View Our Latest Analysis on MCK
Insider Buying and Selling
In other McKesson news, CEO Brian S. Tyler sold 3,753 shares of the firm’s stock in a transaction that occurred on Monday, August 5th. The shares were sold at an average price of $626.03, for a total value of $2,349,490.59. Following the completion of the sale, the chief executive officer now directly owns 82,339 shares in the company, valued at $51,546,684.17. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders sold a total of 11,259 shares of company stock worth $6,635,492 in the last 90 days. 0.11% of the stock is owned by corporate insiders.
McKesson Profile
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.
Read More
- Five stocks we like better than McKesson
- 10 Best Airline Stocks to Buy
- Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge
- How to Use High Beta Stocks to Maximize Your Investing Profits
- How the Fed’s Rate Cut Could Supercharge These 3 ETFs
- Differences Between Momentum Investing and Long Term Investing
- Microsoft Stock: 3 Reasons It’s Ready to Crush Q4
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Co. (NYSE:MCK – Free Report).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.